shutterstock_1712657533 (1).png


Abstract Submission is now closed.

If your abstract is accepted as part of ESPE 2022, your work will be accessible to thousands of clinicians and researchers working in paediatric endocrinology.

Abstract Deadline – Tuesday 19 April 2022 (23:59 BST)

Authors will be informed of the decision of their abstract in June 2022.

Abstract Guidelines

  • Abstracts must be no longer than 400 words.
  • Do not include your title or author list in the body of the abstract as these will be added separately.
  • Abstracts and titles must be submitted in English.
  • Tables can be included in the abstract text but will be included in the word count.
  • Figures and images will not be accepted by the submission system.
  • ESPE do not accept encore abstracts – any abstract previously presented at another congress will need to include new data and be re-written for consideration for ESPE 2022.
  • At least one author from every accepted abstract must register to attend ESPE 2022.

Benefits of submitting

Sharing an abstract also gives you the opportunity to get useful feedback, helping you to progress your work, and boost your networking and presentation skills.

There are several prizes and grants associated with high scoring accepted abstracts, including for undergraduates.

Please note that abstracts are accepted on the understanding that the work has not been published or presented elsewhere.

Accepted abstracts will be presented at the virtual event as an ePoster or as an oral presentation, and will be published online in Hormone Research in Paediatrics.

Please be aware that ESPE will not be re-opening for late-breaking submissions this year.

Undergraduates may be interested in the ESPE Undergraduate Achievement Award. This award is for all undergraduates who submit a successful abstract to the ESPE Annual Congress.

The abstract categories are:

  • Diabetes and insulin
  • Fat, metabolism and obesity
  • Thyroid
  • Bone, growth plate and mineral metabolism
  • GH and IGFs
  • Adrenals and HPA Axis
  • Growth and syndromes (to include Turner syndrome)
  • Pituitary, neuroendocrinology and puberty
  • Sex differentiation, gonads and gynaecology or sex endocrinology
  • Fetal, neonatal endocrinology and metabolism (to include hypoglycaemia)
  • Multisystem endocrine disorders

For any queries regarding your abstract please contact the Abstracts Manager at